Compare CVS Health Corp (CVS) vs Centrus Energy Corp (LEU) Price & Performance

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.

Centrus Energy (LEU) trades at $191.37, up 7.49% in 24 hours, showing strong momentum amid bullish technical signals. Recent Q2 2026 earnings beat expectations with EPS of $0.77 versus $0.732 expected, though revenue growth is tempered by margin compression. The company secured a $900 million DOE contract and expanded its backlog to $4.5 billion, positioning it for long-term nuclear fuel demand. Analysts maintain a consensus buy rating with a $228.50 price target, reflecting optimism in its HALEU market dominance.

Outlook is positive due to government support and backlog visibility, but risks include high valuation (P/E 68.23), volatile cash flows, and execution challenges in scaling production. Investors should weigh growth potential against cost pressures and competitive dynamics in the nuclear sector.